Determinants in Initial Treatment Choice for Diabetic Macular Edema.

ABSTRACT:

Purpose

To assess how patient choices (out-of-pocket costs, insurance plan, geographic region) impact initiation of therapy for diabetic macular edema (DME).

Design

Retrospective cohort study using administrative medical claims data from a large, national insurer.

Participants

All patients newly diagnosed with DME from 2013 through 2016 were observed for 90 days after diagnosis or until first treatment was received.

Methods

Multivariate logistic regression was used to create odds ratios comparing different baseline demographic and patient-related factors.

Main outcome measures

The primary outcome was the odds of receiving the different possible initial treatments for DME (anti-vascular endothelial growth factor [VEGF], focal laser treatment, steroids, or

SUBMITTER: VanderBeek BL 

PROVIDER: S-EPMC6875609 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature